Form 4 for NUTX Nutex Health Inc.
Accepted 2023-10-05 00:00:00 ET · period of report 2023-09-22 · accession 0001486189-23-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-05 | 2023-09-22 | NUTX | Hosseinion Warren | Pres, Dir | G - Gift | $0.00 | -141.0K | 107.7K | -57% | $0 |
| DM | 2023-10-05 | 2023-10-03 | NUTX | Hosseinion Warren | Pres, Dir | G - Gift | $0.00 | -60.8K | 10.8K | -85% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-22 | G | D | 141,000 | $0.00 | 107,678 | D | — | — | |
| 2 | Derivative | Stock Options (Right to Buy) | 2023-10-03 | G | D | 50,000 | $0.00 | 1,609,779 | D | $1.50 · 2020-01-27 to 2030-01-27 | 50,000 Common Stock | (F1) The options were granted pursuant to the Issuers 2019 Omnibus Equity Incentive Plan and Amended and Restated Nutex Health Inc. 2023 Equity Incentive Plan. |
| 3 | Derivative | Warrants | 2023-10-03 | G | D | 10,795 | $0.00 | 10,795 | D | $6.67 · 2019-03-21 to 2024-12-31 | 10,795 Common Stock |